Align Technology Inc (ALGN) · Nov 5, 2026 · Other events
$270M buyback — 2026 repurchases expected at approximately $500M; $270M ASR fulfills July commitment
Align’s new $270M buyback executes its already-announced 2026 capital-return plan, leaving $330M authorized for future repurchases.
Align is a clear-aligner and digital-dentistry platform trying to sustain volume and margin growth while discretionary dental spending remains soft and scanner demand shifts toward lower-priced, flexible purchase models. Its latest quarterly update had already called for approximately $500 million of 2026 buybacks, alongside clear-aligner growth and improved profitability, so this filing mainly turns that commitment into a formal transaction rather than changing the operating story.
| Item | Current | Context |
|---|---|---|
| ASR value (ASR terms) | $270M | July commitment |
| Expected 2026 repurchases (Press release) | ~$500M | $400M–$500M prior range |
| Initial shares delivered (ASR terms) | ~1.44M | Final amount market-price dependent |
| Remaining authorization (Press release) | ~$330M | $1.0B program |
| Cash and equivalents (Press release) | ~$1.145B | September 30, 2026 |
The filing confirms execution, not a new capital-allocation decision. Align will prepay Goldman Sachs $270 million and receive approximately 1.44 million shares initially; the final share count depends on the average trading price during the ASR. The company explicitly says the transaction fulfills the share-repurchase commitment announced in July and should bring total 2026 repurchases to approximately $500 million.
The balance-sheet signal is supportive but not transformative. The ASR is funded with cash on hand, while Align reports approximately $1.145 billion of cash and expects roughly $330 million to remain under the authorization. That preserves flexibility, but the filing does not add new operating guidance, improve the demand outlook, or alter the previously disclosed 2026 buyback target.
Bottom line: This is a routine implementation of an already-known $500 million capital-return plan. It reinforces cash-generation confidence, but barely changes Align’s underlying business story.
ASR final settlement, by December 29, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!